NeurotechMagProGet access
Clinical Trial

Engaging the Subgenual Cingulate With Brain Stimulation for Depression

ClinicalTrials.gov2/20/2024ยท02/20/24๐ŸŒ USA

Summary

The purpose of this study is to investigate the responses of the brain region known as the subgenual anterior cingulate cortex (sgACC) during transcranial magnetic stimulation (TMS) in individuals with depression. Specifically, investigators aim to determine whether the sgACC is engaged when TMS is delivered to specific targets and if the engagement of sgACC changes throughout a full TMS treatment intervention.

Why it matters

This trial represents an important advancement in neurotechnology for treating Depression. If successful, the device-based intervention could provide a new therapeutic option for patients who have not responded adequately to conventional treatments or therapies. The study results may inform future regulatory approval pathways and establish clinical precedent that could benefit broader patient populations with similar conditions.

#Phase 1#TMS#Depression#Neurostimulation

Want the full NeurotechMag Pro intelligence database?

Access 800+ papers, trials, patents, funding rounds and news items โ€” updated daily.

Start free trial
Already a member? Sign in